OIL & GAS

Cognos, the world leader in business intelligence and corporate performance management (CPM), announced today that Quintiles Transnational Corp. is standardizing on Cognos' industry-leading BI series to provide its customers with in-depth, timely sales force performance and clinical product development analytics, as well as enable greater corporate reporting through executive scorecards. Quintiles Transnational is the world's leading provider of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Following a rigorous review of business intelligence solutions in the market, Quintiles selected Cognos to be the BI standard for two of its business units in particular -- Commercial Services, which provides customers with specialized pre-launch, launch and post-launch fee-for-service contract sales and strategic marketing services; and Product Development Services, which offers customers all phases of clinical research and outcomes research cons ulting. Using Cognos BI, including Cognos ReportNet and Cognos PowerPlay, Commercial Services staff will be able to more effectively consolidate, analyze and report on sales data received from satellite offices around the world. Customers would then benefit from transparent, Web-based access to more timely sales performance reports, trends analysis and forecasts. Similarly, Product Development Services staff will leverage Cognos to improve the timeliness of operational reports and trends analysis that are tailored to the company's clinical performance objectives. In addition, Quintiles will deploy Cognos Metrics Manager to help senior executives actively monitor and analyze results against key performance indicators. "Our customers require timely, accurate and relevant information that can help them measure and analyze performance against program objectives," said Marilee McTigue, vice president of IT strategy and planning at Quintiles Transnational. "With Cognos, operational as well as market information will be more transparent to the customer. Customers will also be able to personalize their view of their data, drill into their numbers, uncover trends and adjust their plans to improve performance." "Pharmaceutical companies face tremendous costs to support their research, development and sales and marketing initiatives. This fuels the need for effective performance management solutions that can drive cost savings, and maximize operational effectiveness," said Bill Stevens, director of life sciences industry solutions at Cognos. "Cognos is very pleased to be working together with Quintiles. Coupling their expertise in pharmaceutical services with our leading business intelligence and performance analytics solutions will give their customers the competitive advantage they need to succeed." Cognos is one of the leading providers of BI and corporate performance management solutions for the pharmaceutical industry. Currently, 24 of the top 30 pharmaceutical firms rely on Cognos performance management software. For more information about Cognos solutions for pharmaceuticals and life sciences, please visit http://www.cognos.com/solutions/industry//pharmaceuticals-life- sciences/index.html.